Exchange Traded Concepts LLC Purchases 7,914 Shares of UnitedHealth Group Incorporated $UNH

Exchange Traded Concepts LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 189.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,098 shares of the healthcare conglomerate’s stock after purchasing an additional 7,914 shares during the period. Exchange Traded Concepts LLC’s holdings in UnitedHealth Group were worth $4,177,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the business. LFA Lugano Financial Advisors SA bought a new position in UnitedHealth Group in the second quarter worth approximately $25,000. Bayforest Capital Ltd raised its holdings in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares during the period. Sagard Holdings Management Inc. bought a new stake in UnitedHealth Group during the second quarter valued at about $29,000. Islay Capital Management LLC bought a new position in shares of UnitedHealth Group in the second quarter worth about $31,000. Finally, Riggs Asset Managment Co. Inc. grew its stake in shares of UnitedHealth Group by 69.4% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 43 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.7%

UNH stock opened at $327.08 on Thursday. The firm has a market cap of $296.28 billion, a PE ratio of 17.07, a price-to-earnings-growth ratio of 2.12 and a beta of 0.43. The firm has a fifty day moving average price of $334.77 and a 200 day moving average price of $318.74. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $606.36.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter last year, the business earned $7.15 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend was Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

Analyst Ratings Changes

UNH has been the topic of several analyst reports. Mizuho lifted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Wells Fargo & Company lifted their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Piper Sandler dropped their price objective on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research note on Tuesday, October 28th. Finally, Weiss Ratings raised UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 24th. Seventeen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Hold” and a consensus price target of $385.54.

Get Our Latest Report on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.